Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

"Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention" was originally created and published by ...

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

A non-reactive result in an HIV test generally means that you don't have HIV. It may also mean you tested too soon after ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

A report by Ghana HIV and AIDS Network (GHANET), as part of its Community HIV self-testing project, has revealed that petty ...

Health and resource organizations will host free testing events across locations in Dallas on Friday for National HIV Testing ...